Samplix provides better sample preparation of DNA by eliminating errors and bias, which allows for better sequencing and thereby better healthcare. Sample preparation for sequencing is a $3bn market opportunity growing 20% annually. Samplix' Xdrop™ technology comprises both an instrument and cartridges. The company's razor/razor blade business model is highly scalable and is based on subscription based supply of consumables.   Management has extensive industry experience.